Table 5 Ultrasonographic characterization by Doppler (intensity, location and vascularization pattern, systolic peak, diastolic velocity, resistivity index, and pulsatility index) of cutaneous and subcutaneous canine neoplasms for tumor types that presented two or more cases

Sebaceous adenoma

(6)

Absent 33.3%

Discrete 16.7%

Moderate 50%

Intense 0%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 25%

Network 75%

8.4 ± 2.21

2.8 ± 1.22

0.67 ± 0.12

2.03 ± 1.14

Basal cell carcinoma

(2)

Absent 0%

Discrete 100%

Moderate 0%

Intense 0%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 0%

Network 100%

16.73 ± 29.18

4.45 ± 5.88

0.7 ± 0.11

5.0 ± 9.32

Squamous cell carcinoma

(15)

Absent 80%

Discrete 13.3%

Moderate 0%

Intense 6.7%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 66.7%

Network 33.3%

10.15 ± 8.55

5.5 ± 5.65

0.52 ± 0.15

1.52 ± 0.91

Mixed carcinoma (2)

Absent 100%

Discrete 0%

Moderate 0%

Intense 0%

NA

NA

NA

NA

NA

NA

Apocrine cystadenoma

(2)

Absent 50%

Discrete 50%

Moderate 0%

Intense 0%

Central 0%

Peripheral 100%

Diffuse 0%

Perinodular 100%

Mosaic 0%

Network 0%

NA

NA

NA

NA

Fibrosarcoma

(4)

Absent 75%

Discrete 25%

Moderate 0%

Intense 0%

Central 0%

Peripheral 50%

Diffuse 50%

Perinodular 0%

Mosaic 100%

Network 0%

NA

NA

NA

NA

Cavernous hemangioma

(6)

Absent 50%

Discrete 50%

Moderate

Intense

Central 0%

Peripheral 33.3%

Diffuse 66.7%

Perinodular 0%

Mosaic 100%

Network 0%

5.85 ± 1.77

2.35 ± 0.35

0.58 ± 0.06

1.06 ± 0.17

Hemangiosarcoma

(5)

Absent 80%

Discrete 20%

Moderate 0%

Intense 0%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 100%

Network 0%

9.2*

3.4*

0.63*

4.14*

Cutaneous lymphoma

(13)

Absent 38.5%

Discrete 53.8%

Moderate 7.7%

Intense 0%

Central 0%

Peripheral 62.5%

Diffuse 37.5%

Perinodular 62.5%

Mosaic 37.5%

Network 0%

64.7 ± 40.91

18.8 ± 17.16

0.73 ± 0.18

2.18 ± 1.35

Lipoma

(17)

Absent 70.6%

Discrete 23.5%

Moderate 5.9%

Intense 0%

Central 20%

Peripheral 20%

Diffuse 60%

Perinodular 0%

Mosaic 40%

Network 60%

18.03 ± 5.71

8.67 ± 1.24

0.49 ± 1.74

0.82 ± 0.58

High-grade cutaneous mast cell tumor (24)

Absent 4.2%

Discrete 33.3%

Moderate 41.7%

Intense 20.8%

Central 13%

Peripheral 8.7%

Diffuse 78.3%

Perinodular 4.4%

Mosaic 39.1%

Network 56.5%

17.07 ± 23.89

5.02 ± 5.18

0.66 ± 0.12

3.87 ± 7.2

Low-grade cutaneous mast cell tumor (10)

Absent 40%

Discrete 40%

Moderate 20%

Intense 0%

Central 16.7%

Peripheral 33.3%

Diffuse 50%

Perinodular 0%

Mosaic 66.7%

Network 33.3%

28.76 ± 40.17

4.35 ± 5.56

0.67 ± 0.1

4.47 ± 8.83

Infiltrative subcutaneous mast cell tumor (2)

Absent 0%

Discrete 0%

Moderate 100%

Intense 0%

Central 100%

Peripheral 0%

Diffuse 0%

Perinodular 0%

Mosaic 0%

Network 100%

2.31 ± 1.12

5.0 ± 4.21

0.78 ± 0.1

4.11 ± 2.32

Amelanotic melanoma (9)

Absent 33.3%

Discrete 16.7%

Moderate 0%

Intense 50%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 25%

Network 75%

18.55 ± 27.51

4.89 ± 5.81

0.69 ± 0.11

4.29 ± 7.89

Grade II soft tissue sarcoma (7)

Absent 0%

Discrete 0%

Moderate 50%

Intense 50%

Central 0%

Peripheral 0%

Diffuse 100%

Perinodular 0%

Mosaic 0%

Network 100%

8.98 ± 6.56

3.37 ± 2.59

0.66 ± 0.1

4.57 ± 8.44